Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah A Richman

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biomolecular Engineering|April 6, 2007
Display, engineering, and applications of antigen-specific T cell receptorsSarah A Richman, David M Kranz
Immunology and Cell Biology|June 14, 2019
β-synuclein at the "synapse" of encephalitis and neurodegeneration in multiple sclerosis?Sarah A Richman, Christopher A Hunter
Cancer Immunology Research|April 4, 2018
Neurotoxicity Associated with a High-Affinity GD2 CAR-ResponseSarah A Richman, Michael C Milone
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2009
Biosensor detection systems: engineering stable, high-affinity bioreceptors by yeast surface displaySarah A Richman, David M Kranz, Jennifer D Stone
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2020
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In VivoSarah A Richman, Liang-Chuan Wang, Edmund K Moon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2020
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In VivoSarah A Richman, Liang-Chuan Wang, Edmund K Moon, et al.
Blood|May 16, 2013
Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selectionThomas M Schmitt, David H Aggen, Ingunn M Stromnes, et al.
Molecular Immunology|October 31, 2008
Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragmentsSarah A Richman, David H Aggen, Michelle L Dossett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2019
Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter GeneMark A Sellmyer, Sarah A Richman, Katheryn Lohith, et al.
Cancer Immunology Research|November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelSarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomolecular Engineering|April 6, 2007
Display, engineering, and applications of antigen-specific T cell receptorsSarah A Richman, David M Kranz
Immunology and Cell Biology|June 14, 2019
β-synuclein at the "synapse" of encephalitis and neurodegeneration in multiple sclerosis?Sarah A Richman, Christopher A Hunter
Cancer Immunology Research|April 4, 2018
Neurotoxicity Associated with a High-Affinity GD2 CAR-ResponseSarah A Richman, Michael C Milone
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2009
Biosensor detection systems: engineering stable, high-affinity bioreceptors by yeast surface displaySarah A Richman, David M Kranz, Jennifer D Stone
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2020
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In VivoSarah A Richman, Liang-Chuan Wang, Edmund K Moon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2020
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In VivoSarah A Richman, Liang-Chuan Wang, Edmund K Moon, et al.
Blood|May 16, 2013
Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selectionThomas M Schmitt, David H Aggen, Ingunn M Stromnes, et al.
Molecular Immunology|October 31, 2008
Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragmentsSarah A Richman, David H Aggen, Michelle L Dossett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2019
Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter GeneMark A Sellmyer, Sarah A Richman, Katheryn Lohith, et al.
Cancer Immunology Research|November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelSarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.
Pageof 2